Skip to main content
BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.720
+0.120 (2.61%)
At close: Apr 28, 2026

BioStem Technologies Revenue

In the year 2025, BioStem Technologies had annual revenue of $47.48M, down -84.27%. BioStem Technologies had revenue of $10.08M in the quarter ending December 31, 2025, a decrease of -90.20%.

Revenue
47.48M
Revenue Growth
-84.27%
P/S Ratio
1.69
Revenue / Employee
1.44M
Employees
33
Market Cap
80.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202547.48M-254.35M-84.27%
Dec 31, 2024301.83M285.14M1,708.93%
Dec 31, 202316.69M9.81M142.69%
Dec 31, 20226.88M2.53M58.38%
Dec 31, 20214.34M4.03M1,284.88%
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nuo Therapeutics 3.31M
Vaxart 237.26M
Harvard Apparatus Regenerative Technology 704.00K
Arch Biopartners 115.29K
Provectus Biopharmaceuticals 336.11K
Revenue Rankings

BioStem Technologies News

More News